Kristin Robidou
Family Medicine · Stockton, MONPI 1639564404
Payments from drug & device makers
Across 105 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$482
- Novo Nordisk$452
- Lilly USA, LLC$172
- Amgen$108
- Otsuka America Pharmaceutical, Inc.$90
- Abbott$89
- plus $510 from 17 others
What the payments were for
- Food & beverage$1,901100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $482 |
| Novo Nordisk | 24 | $452 |
| Lilly USA, LLC | 11 | $172 |
| Amgen | 7 | $108 |
| Otsuka America Pharmaceutical, Inc. | 4 | $90 |
| Abbott | 4 | $89 |
| AstraZeneca | 5 | $75 |
| Novartis | 3 | $67 |
| Lundbeck LLC | 2 | $49 |
| Dexcom, Inc. | 3 | $45 |
| Globus Medical | 1 | $33 |
| Pfizer | 2 | $30 |
| Exact Sciences | 2 | $28 |
| Eisai Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Organon | 2 | $22 |
| Astellas Pharma US Inc | 1 | $22 |
| Alkermes, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Merck | 1 | $15 |
| GSK | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $13 |
| Bayer | 1 | $13 |
How this compares
$1,901 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 101 | $105,304 |
| OzempicSemaglutide | 71 | $69,963 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 75 | $67,667 |
| MounjaroTirzepatide | 43 | $45,576 |
| JardianceEmpagliflozin | 33 | $34,717 |
| RybelsusSemaglutide | 21 | $25,681 |
| JanuviaSitagliptin Phosphate | 26 | $23,829 |
| XareltoRivaroxaban | 17 | $22,746 |
| VraylarCariprazine Hcl | 14 | $18,912 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 32 | $14,018 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $12,345 |
| TrulicityDulaglutide | 12 | $11,709 |
| LinzessLinaclotide | 15 | $10,773 |
| Repatha SureclickEvolocumab | 15 | $10,527 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $9,695 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $30 | $105,304101 claims |
| Novo NordiskOzempic, Rybelsus | $452 | $95,64592 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arexvy | $15 | $90,443123 claims |
| Lilly USA, LLCMounjaro, Trulicity | $172 | $57,28655 claims |
| Boehringer IngelheimJardiance, Tradjenta | $17 | $41,81446 claims |
| AbbVieVraylar, Linzess, Lumigan | $482 | $32,81241 claims |
| MerckJanuvia | $15 | $23,82926 claims |
| AstraZenecaSymbicort | $75 | $4,52317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Stockton
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.